Skip to main content
Premium Trial:

Request an Annual Quote

Janney Montgomery Scott Downgrades Illumina

NEW YORK (GenomeWeb) – Following Illumina's miss on the consensus Wall Street estimate for its revenues, investment bank Janney Montgomery Scott today downgraded shares of the firm to a Neutral rating from a previous Buy rating. 

"With revenue growth decelerating, we see limited expansion to the 50.4X" price/earning multiple for Illumina in 2017, analyst Paul Knight wrote in a research note. He maintained the fair value of Illumina's shares at $240. 

On Tuesday, Illumina reported revenues of $539.4 million for the second quarter, a 21 percent increase year over year but short of the analyst average estimate of $541.8 million.

In his note, Knight noted concerns about both Illumina's sequencing and microarray businesses. While Illumina's sequencing revenues grew a "robust" 28 percent year over year and Knight estimated a 23 percent to 27 percent growth rate for the remainder of the year, some have suggested that long-term growth in the whole-genome sequencing space will slow as researchers move to application-specific methods. 

"The sequential slowdown in [Illumina's] instrument growth lends credence to this viewpoint and the robust growth seen in clinical/translational medicine and oncology further supports a shifting demand," Knight wrote. "We believe this dynamic deserves further inspection for [Illumina's] investors." 

Meanwhile, Illumina's microarray business fell in the double digits. "We expected a better performance from the array segment," Knight said. 

In afternoon trading Illumina's shares were down 8 percent to $217.85 on the Nasdaq.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.